Ellen Hollywood

Randomized Phase II Trial of Cetuximab, Bevacizumab, and Irinotecan Compared With Cetuximab and Bevacizumab Alone in Irinotecan-Refractory Colorectal Cancer: The BOND-2 Study

Leonard B. Saltz, Heinz‐Josef Lenz, Hedy L. Kindler et al. · Journal of Clinical Oncology · 2007 · 427 citations · Full text

Medicine, Oncology, Pharmacology +14

Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for Patients With Locally Advanced Rectal Cancer: A Pilot Trial

Deborah Schrag, Martin R. Weiser, Karyn A. Goodman et al. · Journal of Clinical Oncology · 2014 · 424 citations · Full text

Medicine, Oncology, Surgery +17

The pharmacokinetics, toxicities, and biologic effects of FK866, a nicotinamide adenine dinucleotide biosynthesis inhibitor

Kyle D. Holen, Leonard B. Saltz, Ellen Hollywood et al. · Investigational New Drugs · 2007 · 292 citations

Medicine, Pharmacokinetics, Pharmacology +14

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

Ghassan K. Abou‐Alfa, Shukui Qin, Baek‐Yeol Ryoo et al. · Annals of Oncology · 2018 · 255 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer

Leonard B. Saltz, Heinz‐Josef Lenz, Howard S. Höchster et al. · Journal of Clinical Oncology · 2005 · 182 citations

Medicine, Oncology, Pharmacology +17